In the breast cancer model, we found that mice with GCSF−/− tumors responded better than those with GCSF-expressing tumors to injection of tumor-reactive OT-I T cells, developing smaller tumors and exhibiting increased survival. The gene discussed is CSF3; the disease is neoplasm.